Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

INSERT INTO chat_queries_log (query_id, drugname, ip, country, time_sent) VALUES ( "452193", "Sirolimus", "216.73.217.79", "US", NOW() )

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Sirolimus c01eb l01eg l04ah s01xa?

See the DrugPatentWatch profile for Sirolimus

What does “Sirolimus c01eb l01eg l04ah s01xa” mean?

Those codes are a shorthand classification system used to group medicines by their therapeutic use:

- C01EB: drugs for heart disease, classified under a specific “EB” subgroup.
- L01EG: antineoplastic (cancer) medicines, within subgroup “EG”.
- L04AH: immunosuppressants (used to prevent transplant rejection and in some immune conditions), within subgroup “AH”.
- S01XA: ophthalmic drugs (eye medicines), within subgroup “XA”.

Because the same active ingredient is sometimes listed under more than one therapeutic area depending on formulation and jurisdiction, the same name (sirolimus) can appear across multiple code categories. The codes you provided indicate that sirolimus is associated with at least those therapeutic groupings in the classification system being used.

Is sirolimus used for cancer, transplant rejection, or eye diseases?

Sirolimus is primarily known as:
- An immunosuppressant used to prevent organ transplant rejection.
- An antineoplastic agent in certain cancer contexts (for example, some drug-eluting stents and trials/regimens, depending on product and country).
- Ophthalmic use can exist in some settings, but it depends heavily on the specific eye formulation and regulatory approval.

The presence of both L01EG and L04AH points to use spanning anticancer and immunosuppressive roles, while S01XA suggests an eye-related classification for an approved ophthalmic preparation (or a classification mapping in that system).

What are the most common brand/formulation examples?

“Sirolimus” can refer to different products (and different routes of administration), such as:
- Oral/for-transplant formulations (systemic immunosuppression).
- Specialized localized forms (including devices or compounded/approved variants, depending on country).
Ophthalmic classification (S01XA) would apply only if there is a specific eye formulation recognized under that code in the classification source you are using.

Which exact medicine should I identify from these codes?

To pinpoint the exact product, you’d typically need at least one of the following:
- The full ATC code string (including any additional digits beyond what you typed).
- The country/registry the codes come from (ATC system is common, but code mappings can differ by dataset).
- The dosage form (tablet, oral solution, topical/eye drop, etc.).

If you tell me the source of these codes (for example, the country database or whether these are ATC/DDD codes from a specific site), I can help interpret them more precisely.

Sources

No specific source links were provided with your input, and the codes alone don’t uniquely identify a single product without the originating classification dataset.



Other Questions About Sirolimus :

Sirolimus 2mg tablet price? Sirolimus price per tablet? Sirolimus fda exclusivity date? Sirolimus cost? Sirolimus cost without insurance? Sirolimus lymos us market launch date? Sirolimus trade name?